...
首页> 外文期刊>Pediatrics: Official Publication of the American Academy of Pediatrics >An Evaluation of Dietary Protein in the Treatment of Liver Disease
【24h】

An Evaluation of Dietary Protein in the Treatment of Liver Disease

机译:膳食蛋白治疗肝病的评价

获取原文
           

摘要

This paper is a review of the oscillations in authoritative opinion regarding the proper protein content of the diet for patients with liver disease that have characterized the period since 1937. This period began with enthusiasm for a high-protein diet and ends with uncertainty as to the degree of concern which one should have over the recent re-discovery of the role of toxic effects of protein in relation to hepatic coma. Here one may gain insight into the complexities which surround clinical investigation of what may appear to be a simple question. A series of tentative conclusions, unsupported by adequate controlled studies, became successively generally accepted as authoritative opinion. The author cautions that the recent interest in toxic effects of protein in patients with hepatic coma should not be extended uncritically to all patients with liver disease, some of whom may receive benefit from high-protein intakes without risk from harm of toxic effects on the brain. He makes a plea for the conduct of meticulously controlled therapeutic trials to guide us in the selection of the proper protein intake for patients with various forms of liver disease.
机译:本文回顾了自1937年以来肝病患者饮食中适当蛋白质含量的权威性观点波动。这一时期始于对高蛋白饮食的热情开始,并最终因对高蛋白饮食的不确定性而结束。最近重新发现蛋白质毒性作用与肝昏迷之间的关系时应引起关注的程度。在这里,人们可能会发现围绕临床研究的复杂性,这似乎是一个简单的问题。一系列的初步结论,没有适当的对照研究的支持,逐渐被公认是权威性的观点。作者告诫说,对肝昏迷患者蛋白质毒性作用的最新兴趣不应无限制地扩展到所有肝病患者,其中一些人可能会从高蛋白摄入中受益,而不会受到对大脑毒性作用的危害。他呼吁进行严格控制的治疗试验,以指导我们为各种形式的肝病患者选择合适的蛋白质摄入量。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号